| Dr Bonnie Suzanne Huber, MD | |
|
12607 Se Mill Plain Blvd, Northwest Permanente, Vancouver, WA 98684-6055 | |
| (360) 896-4460 | |
| (360) 896-4478 |
| Full Name | Dr Bonnie Suzanne Huber |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 19 Years |
| Location | 12607 Se Mill Plain Blvd, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104029545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD 14234 (Hawaii) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD 60341605 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces that a Luxembourg incorporated wholly-owned subsidiary of Shire plc will launch a voluntary public takeover offer for all the shares in Movetis NV, the Belgium-based European specialty gastrointestinal (GI) company. Movetis is listed on Euronext and focuses on discovering, developing and commercializing innovative treatments for GI conditions with a high unmet medical need.
A recent 'tour-de-force' research endeavor, led by scientists from Harvard University, explored the propensity of a biomaterial vaccine based on mesoporous silica rods to spawn highly protective humoral responses against relevant antigens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, together with 26 of the Company's valued supplier partners, join the American Dental Association (ADA) today to celebrate the ADA's annual Give Kids A Smile Day.
Join BioTek Instruments as they introduce the Cytation™ 5 Cell Imaging Multi-Mode Reader at the ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania. BioTek's "Think Possible" philosophy is reflected in their microplate-based imaging, detection, liquid handling and automation solutions and the company will showcase their newest innovations at Booth #349.
An Australian-led study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040220000099 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces that a Luxembourg incorporated wholly-owned subsidiary of Shire plc will launch a voluntary public takeover offer for all the shares in Movetis NV, the Belgium-based European specialty gastrointestinal (GI) company. Movetis is listed on Euronext and focuses on discovering, developing and commercializing innovative treatments for GI conditions with a high unmet medical need.
A recent 'tour-de-force' research endeavor, led by scientists from Harvard University, explored the propensity of a biomaterial vaccine based on mesoporous silica rods to spawn highly protective humoral responses against relevant antigens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, together with 26 of the Company's valued supplier partners, join the American Dental Association (ADA) today to celebrate the ADA's annual Give Kids A Smile Day.
Join BioTek Instruments as they introduce the Cytation™ 5 Cell Imaging Multi-Mode Reader at the ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania. BioTek's "Think Possible" philosophy is reflected in their microplate-based imaging, detection, liquid handling and automation solutions and the company will showcase their newest innovations at Booth #349.
An Australian-led study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bonnie Suzanne Huber, MD 12607 Se Mill Plain Blvd, Northwest Permanente, Vancouver, WA 98684-6055 Ph: (360) 896-4460 | Dr Bonnie Suzanne Huber, MD 12607 Se Mill Plain Blvd, Northwest Permanente, Vancouver, WA 98684-6055 Ph: (360) 896-4460 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces that a Luxembourg incorporated wholly-owned subsidiary of Shire plc will launch a voluntary public takeover offer for all the shares in Movetis NV, the Belgium-based European specialty gastrointestinal (GI) company. Movetis is listed on Euronext and focuses on discovering, developing and commercializing innovative treatments for GI conditions with a high unmet medical need.
A recent 'tour-de-force' research endeavor, led by scientists from Harvard University, explored the propensity of a biomaterial vaccine based on mesoporous silica rods to spawn highly protective humoral responses against relevant antigens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, together with 26 of the Company's valued supplier partners, join the American Dental Association (ADA) today to celebrate the ADA's annual Give Kids A Smile Day.
Join BioTek Instruments as they introduce the Cytation™ 5 Cell Imaging Multi-Mode Reader at the ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania. BioTek's "Think Possible" philosophy is reflected in their microplate-based imaging, detection, liquid handling and automation solutions and the company will showcase their newest innovations at Booth #349.
An Australian-led study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.
› Verified 8 days ago
Valentin Y Avramov, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6926 Ne Fourth Plain Blvd, Vancouver, WA 98661 Phone: 360-993-3000 Fax: 360-993-3047 | |
Pippa Macdonald, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 Se 172nd Ave Ste 220, Vancouver, WA 98684 Phone: 360-882-2778 | |
Dr. Michael Dennis Domash, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2215 Broadway St, Vancouver, WA 98663 Phone: 360-906-7156 Fax: 360-696-3658 | |
Anca Balasu, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2415 Ne 134th St Ste 301, Vancouver, WA 98686 Phone: 360-882-2778 | |
Duncan Borland, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Ste. 460, Vancouver, WA 98664 Phone: 360-256-8865 Fax: 360-256-7127 | |
Bruce C. Johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 748 Se Fairwinds Loop, Vancouver, WA 98661 Phone: 360-695-8476 Fax: 360-567-3033 |